Singhe Hospitals PLC (COSE:SINH.N0000)
Sri Lanka · Delayed Price · Currency is LKR 0.00
0.00 (0.00%)
Price not available due to exchange restrictions
Singhe Hospitals Ratios and Metrics
Market cap in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 9,532 | 8,281 | 1,208 | 992 | 1,121 | 949 | |
Market Cap Growth | 92.17% | 585.71% | 21.74% | -11.54% | 18.18% | 10.00% |
Enterprise Value | 9,546 | 8,319 | 1,341 | 1,258 | 1,409 | 1,273 |
Last Close Price | 22.10 | 19.20 | 2.80 | 2.30 | 2.60 | 2.20 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 39.34 | 38.34 | 10.40 | 40.28 | - | 57.81 |
PS Ratio | 4.42 | 4.30 | 0.80 | 0.78 | 1.05 | 0.95 |
PB Ratio | 7.44 | 7.21 | 1.32 | 1.24 | 2.37 | 1.92 |
P/TBV Ratio | 7.53 | 7.31 | 1.34 | 1.26 | 2.40 | 1.95 |
P/FCF Ratio | 89.90 | 62.77 | 7.48 | 13.20 | 14.93 | 24.13 |
P/OCF Ratio | 29.59 | 32.03 | 5.20 | 8.16 | 9.55 | 9.46 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 4.43 | 4.32 | 0.89 | 0.99 | 1.32 | 1.27 |
EV/EBITDA Ratio | 20.45 | 21.48 | 5.57 | 9.25 | 10.46 | 10.01 |
EV/EBIT Ratio | 27.13 | 25.60 | 7.29 | 14.23 | 17.68 | 25.46 |
EV/FCF Ratio | 90.03 | 63.06 | 8.31 | 16.74 | 18.76 | 32.38 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.20 | 0.23 | 0.26 | 0.35 | 0.62 | 0.69 |
Debt / EBITDA Ratio | 0.55 | 0.63 | 0.89 | 1.74 | 1.90 | 2.67 |
Debt / FCF Ratio | 2.40 | 2.01 | 1.48 | 3.73 | 3.92 | 8.62 |
Net Debt / Equity Ratio | 0.05 | 0.04 | 0.11 | 0.30 | 0.55 | 0.66 |
Net Debt / EBITDA Ratio | 0.16 | 0.12 | 0.42 | 1.73 | 1.93 | 2.57 |
Net Debt / FCF Ratio | 0.63 | 0.36 | 0.62 | 3.13 | 3.45 | 8.31 |
Asset Turnover | 1.20 | 1.17 | 1.06 | 1.09 | 1.11 | 1.05 |
Inventory Turnover | 5.55 | 6.40 | 6.17 | 5.79 | 4.72 | 5.93 |
Quick Ratio | 1.47 | 1.18 | 0.68 | 0.47 | 0.31 | 0.21 |
Current Ratio | 1.94 | 1.65 | 1.15 | 0.88 | 0.90 | 0.79 |
Return on Equity (ROE) | 21.14% | 20.97% | 13.58% | 3.87% | -2.63% | 3.38% |
Return on Assets (ROA) | 12.22% | 12.29% | 8.08% | 4.74% | 5.15% | 3.28% |
Return on Invested Capital (ROIC) | 20.22% | 21.11% | 14.20% | 7.58% | -8.18% | 6.12% |
Return on Capital Employed (ROCE) | 20.90% | 21.30% | 14.80% | 7.60% | 10.30% | 6.40% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 3, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 2.54% | 2.61% | 9.62% | 2.48% | -1.14% | 1.73% |
FCF Yield | 1.11% | 1.59% | 13.37% | 7.58% | 6.70% | 4.14% |